Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies (Q46502899)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2005
edit
Language Label Description Also known as
English
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies
scientific article published in May 2005

    Statements

    Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit